drugset / Trial / NCT00671749

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

NCT00671749

Phase 4 Completed 100 enrolled Galderma R&D
NaSingle-groupOpen-labelTreatment

Summary

This study is to determine the efficacy and safety of 12 week treatment with Differin® Gel 0.3% applied in the evening, in combination with Duac® (Clindamycin/Benzoyl Peroxide Gel) applied in the morning, in Subjects with Acne vulgaris.

Timeline

Start
2007-12
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.3 % Topical
Subject Benzoyl Peroxide Other / unclassified Topical
Subject Clindamycin Unknown Topical

Indications